Entity

Time filter

Source Type


Gonzalez-Canga A.,Spanish Agency of Medicine and Medical Devices | Belmar-Liberato R.,Spanish Agency of Medicine and Medical Devices | Escribano M.,Complutense University of Madrid
Current Pharmaceutical Biotechnology | Year: 2012

The characterisation of ivermectin pharmacokinetics can be used to predict and to ensure an optimal activity in the target species and for designing programmes aimed for parasite control. Ivermectin pharmacokinetic studies performed in several minor ruminant species are reviewed in this paper with the aim of facilitating the adoption of rational basis for the establishment of appropriate dosage schedules. © 2012 Bentham Science Publishers. Source


Belmar-Liberato R.,Spanish Agency of Medicine and Medical Devices | Gonzalez-Canga A.,Spanish Agency of Medicine and Medical Devices | Tamame-Martin P.,GYPISA Talavera Slaughterhouse | Escribano-Salazar M.,Complutense University of Madrid
Veterinarni Medicina | Year: 2011

In the recent past years, important efforts towards the prudent use of antimicrobials have been made in order to optimize antibacterial use, and maximize therapeutic effect while minimizing the development of resistance. Knowledge on the occurrence of resistance in bacteria could help in improving the clinical success of therapeutic decisions. Since the discovery of amoxicillin, this drug has been extensively used throughout the world in veterinary medicine, alone and also in combination with clavulanic acid. This paper provides information regarding the current situation of resistance to amoxicillin (and amoxicillin-clavulanic acid) in animals in Europe. Most data comes from food-animal species, mainly from several national monitoring programmes of antimicrobial resistance, and information on companion animals is also available. Source

Discover hidden collaborations